Gleason Group, Inc. Abbott Laboratories Transaction History
Gleason Group, Inc.
- $492 Million
- Q2 2024
A detailed history of Gleason Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gleason Group, Inc. holds 114 shares of ABT stock, worth $13,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114
Previous 113
0.88%
Holding current value
$13,292
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,133Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.67 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.37 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.67 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $204B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...